Delivery Order SPE2DB20D3103-SPE2DB25FN5Q6
- Not listed
- The Defense Logistics Agency awarded a $10,382.17 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This firm fixed-price contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a direct purchase from the vendor's existing Indefinite Delivery Contract with DLA. The award involved no set-aside designation and was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded a $2,905.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a pharmaceutical product used in cardiovascular treatment. This competitive award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a child delivery order executed under a larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,304.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. The contract, which is a child order under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,630.57 for Corlanor 5 mg tablets (60-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. This competitive award utilized firm fixed-price pricing with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,589.66 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg on December 2, 2025, with completion expected by December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement under a child contract arrangement. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,128.12 delivery order on December 3, 2025, for 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in cardiac care. This is a firm fixed-price, non-set-aside contract with a completion date of December 4, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,147.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.12 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a cardiac medication used to treat heart failure. This firm fixed-price delivery order, issued December 5, 2025, represents a non-set-aside, competitively awarded contract with a completion deadline of December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $3,296.56. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN5Q6Delivery Order
The Defense Logistics Agency awarded a $2,454.26 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. The contract was awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, and employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains through competitively awarded vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 4/23/25 |